EE476 The Cost of Non-Cystic Fibrosis Bronchiectasis (NCFB) Patients with Commercial Insurance or Medicare Coverage in the United States

Abstract

Non-Cystic Fibrosis Bronchiectasis (NCFB) is a chronic, progressive respiratory disorder characterized by irreversibly dilated airways and recurrent pulmonary infections. Concomitant infection with Pseudomonas aeruginosa is associated with greater lung function impairment, more frequent exacerbations, greater hospitalization risk, and mortality. NCFB exacerbations are defined as an increase in daily symptoms including cough, sputum, malaise, fatigue, and difficulty breathing. The cost of NCFB illness with Pseudomonas aeruginosa and frequent acute exacerbations have not been quantified.